The Fujii story: A chronicle of naive disbelief
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
In this issue of the European Journal of Anaesthesiology, the editors retract 12 articles from the Japanese anaesthetist Dr Yoshitaka Fujii (Table 1). The 12 articles are part of 183, all authored by Fujii, that have been retracted during the last few months in a variety of journals. Scientific anaesthesiology has been recently rocked by the Reuben and Boldt affairs, and Fujii represents another blow to the reputation of scientific journals. We are all shocked that this has happened again and it is perhaps appropriate to step back a moment, and critically appraise the chain of events.Table 1: Retracted articles by Fujii et al.It does not come as a surprise to us that systematic reviewers were among the first to become suspicious of Fujii, with his significant output, and the conspicuous pattern of his research papers. In 2001, Kranke et al.1 published a letter in Anesthesia and Analgesia with the odd title ‘Reported data on granisetron and postoperative nausea and vomiting by Fujii et al. are incredibly nice!’. In common with most experts in postoperative nausea and vomiting (PONV), Kranke had become increasingly irritated with Fujii, who was producing an astonishing number of articles dealing with the antiemetic efficacy of the 5HT3 receptor antagonist granisetron in patients undergoing surgery. Even for those who lacked expertise in the critical appraisal of clinical studies, it must have become evident that the Fujii trials were fundamentally different from most other published studies. They were all of the same (limited) size; they were always almost (but only almost) identical; they addressed always the same issues; and, perhaps most strikingly, they reported on very similar numbers of efficacy and drug-related harm. Although there were never obvious duplicates, these trials were clearly not ‘natural’. Kranke et al.,1 in their letter, presented a simple but convincing mathematical approach that provided strong evidence that Fujii's data had been fabricated. They had analysed the reported headache frequencies (a common adverse effect of 5HT3 receptor antagonists) in 21 granisetron trials that had been published by Fujii at that time. They knew that in real life, with binominal distribution, a certain variability was expected. What their analysis found was that the close resemblance of Fujii's published results was unlikely to have arisen by chance. They concluded that ‘there must be an underlying influence causing such incredibly nice data reported by Fujii et al.’1 Subsequently, Fujii was invited by the editors of Anesthesia and Analgesia to publish a reply that satisfied nobody, and the affair was closed. It was not clear, though, why Kranke et al. had not said outright that Fujii was fabricating data. Also, reading their letter today, it seems odd that this analysis was not given a full report. Today, we know that at that time, editors and peer reviewers of various high ranking anaesthesia journals did not want Kranke et al. to declare overtly that there was something rotten here. One year later, Kranke et al. published in Acta Anaesthesiologica Scandinavica a meta-analysis of 27 granisetron trials.2 In a subgroup analysis, they compared the Fujii trials, which at that time made up about two thirds of all granisetron trials, with granisetron trials from other authors. The Fujii trials reported a significantly improved antiemetic efficacy of granisetron. Kranke concluded that results of meta-analyses could be significantly skewed by one dominating centre.2 At that time, at least three different affiliations were listed on Fujii's various publications: Tokyo Medical and Dental University School of Medicine; Toride Kyodo General Hospital; Ibaraki; and University of Tsukuba Institute of Clinical Medicine. Clearly the Fujii phenomenon was not about the impact of a single centre but that of an individual. In addition, the main interest here was not to prove the antiemetic efficacy of granisetron (who cares about granisetron?), but to show that somebody was fabricating data. To top it all, in an accompanying Editorial, Kranke's analysis was dismissed. It argued that different baseline risks in the granisetron studies may have been responsible for the observed differences in outcomes.3 In conclusion, Kranke et al. were allowed to publish their alarming analyses, but the Editorial approach significantly blunted their impact. Interestingly, in the years that followed, the number of studies published by Fujii dropped dramatically, and the proportion of those published in anaesthesia journals, compared with non-anaesthesia journals, decreased sharply from almost 100% before 2000 to less than 35% after 2005 (Fig. 1). At this time, neither editor nor institution had started an official enquiry into Fujii's strange production line. It seemed that the editors of most anaesthesia journals had come to a mutual agreement that the best way to deal with the problem was to ignore it, and to ban future Fujii studies from t
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The analysis of 168 randomised controlled trials to test data integrity
Carlisle, J. B. (2012) · Anaesthesia · doi:10.1111/j.1365-2044.2012.07128.x · Cited by 255 · cited 1×
“Finally, in 2012, Carlisle12 set out to present a huge statistical analysis that convincingly reinforced the previous message from Kranke et al. It looked as if the earlier Editorial by Moore had triggered Carlisle’s ambition to nail Fujii down, some years after he had included, perhaps a bit…”
BackgroundFraud or flawed: adverse impact of fabricated or poor quality research
Moore, R. A., Derry, S., & McQuay, H. J. (2010) · Anaesthesia · doi:10.1111/j.1365-2044.2010.06295.x · Cited by 62
Hudes, M. L., McCann, J. C., & Ames, B. N. (2009) · The FASEB Journal · doi:10.1096/fj.08-108910 · Cited by 12
Cited by
Bornemann-Cimenti, H., Szilagyi, I. S., & Sandner-Kiesling, A. (2016) · Science and Engineering Ethics · doi:10.1007/s11948-015-9680-y · Cited by 87
“Critical examination of their work is still ongoing (Wise 2013; Tramer 2013).”
BackgroundElia, N., Wager, E., & Tramèr, M. R. (2014) · PLoS ONE · doi:10.1371/journal.pone.0085846 · Cited by 67
“Since, an even larger case of scientific misconduct, necessitating the retraction of 183 articles, has been uncovered [21].”
BackgroundSelf-citationTeam size and retracted citations reveal the patterns of retractions from 1981 to 2020
Sharma, K. (2021) · Scientometrics · doi:10.1007/s11192-021-04125-4 · Cited by 45
“Yoshitaka Fujii and Joachim Boldtwere, researchers of anesthesia study found guilty of scientific misconduct in 183 and 90 publications, respectively (Tramèr, 2013; Wise, 2013).”
BackgroundMott, A., Fairhurst, C., & Torgerson, D. (2019) · Journal of Health Services Research & Policy · doi:10.1177/1355819618797965 · Cited by 36
Wiedermann, C. J. (2018) · Accountability in Research · doi:10.1080/08989621.2018.1450143 · Cited by 16
Metadata
- Authors
- Tramèr, M. R.
- Venue
- European Journal of Anaesthesiology
- Published
- 2013-05
- Volume
- 30
- Issue
- 5
- Pages
- 195-198
- ISSN
- 0265-0215 (ISSN-L)
- OpenAlex
- W2029556040
- Cited by
- 34
- References
- 3
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.